Sphingosine-1-phosphate and immune regulation: Trafficking and beyond

Trends in Pharmacological Sciences

Volumn 32, Issue 1, 2011, Pages 16-24

  Chi, Hongbo ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 [2 [4 (3 BENZYLOXYPHENYLTHIO) 2 CHLOROPHENYL]ETHYL] 1,3 PROPANEDIOL; 5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; BETA1A INTERFERON; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; FC RECEPTOR; FINGOLIMOD; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; LYASE; MAMMALIAN TARGET OF RAPAMYCIN; MONOCLONAL ANTIBODY; N,N DIMETHYLSPHINGOSINE; PLACEBO; PROTEIN KINASE C GAMMA; PROTEINASE ACTIVATED RECEPTOR 1; RAPAMYCIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE ANTIBODY; SPHINGOSINE 1 PHOSPHATE LYASE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; SPHINGOSINE KINASE INHIBITOR; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGIC DISEASE; ANAPHYLAXIS; ATRIOVENTRICULAR BLOCK; AUTOIMMUNE DISEASE; AUTOIMMUNE MYOCARDITIS; BRADYCARDIA; CD4+ T LYMPHOCYTE; CHRONIC COLITIS; CHRONIC GRAFT REJECTION; COLITIS; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG DOSE COMPARISON; DRUG TARGETING; GENE SILENCING; GRAFT REJECTION; HEPATITIS; HUMAN; HYPERTENSION; IMMUNOREGULATION; INFECTION; INFLAMMATION; INNATE IMMUNITY; INTERNALIZATION; INTRACELLULAR SIGNALING; KIDNEY ISCHEMIA; LIPID DEGRADATION; LUPUS VULGARIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MAST CELL; MEMORY T LYMPHOCYTE; MULTIPLE SCLEROSIS; MYOCARDITIS; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REPERFUSION INJURY; RETINA MACULA EDEMA; REVIEW; SEPSIS; SIDE EFFECT; TH1 CELL; TH17 CELL; TH2 CELL; UBIQUITINATION;

ALDEHYDE-LYASES; ANIMALS; CELL DIFFERENTIATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LYMPHOCYTES; LYSOPHOSPHOLIPIDS; MOLECULAR TARGETED THERAPY; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 78650881166     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2010.11.002     Document Type: Review

References (81)

1. H. Rosen Sphingosine 1-phosphate receptor signaling Annu. Rev. Biochem. 78 2009 743 768
2. J. Rivera The alliance of sphingosine-1-phosphate and its receptors in immunity Nat. Rev. Immunol. 8 2008 753 763
3. R. Pappu Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate Science 316 2007 295 298
4. K. Venkataraman Vascular endothelium as a contributor of plasma sphingosine 1-phosphate Circ. Res. 102 2008 669 676
5. M.A. Zachariah, and J.G. Cyster Neural crest-derived pericytes promote egress of mature thymocytes at the corticomedullary junction Science 328 2010 1129 1135
6. T.H. Pham Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning J. Exp. Med. 207 2010 17 27
7. S.R. Schwab Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients Science 309 2005 1735 1739
8. S.R. Schwab, and J.G. Cyster Finding a way out: lymphocyte egress from lymphoid organs Nat. Immunol. 8 2007 1295 1301
9. D. Marsolais, and H. Rosen Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules Nat. Rev. Drug Discov. 8 2009 297 307
10. S. Mandala Alteration of lymphocyte trafficking by sphingosine-1- phosphate receptor agonists Science 296 2002 346 349
11. V. Brinkmann The immune modulator FTY720 targets sphingosine 1-phosphate receptors J. Biol. Chem. 277 2002 21453 21457
12. M. Matloubian Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 Nature 427 2004 355 360
13. M.L. Allende Expression of the sphingosine 1-phosphate receptor. S1P1, on T-cells controls thymic emigration J. Biol. Chem. 279 2004 15396 15401
14. H. Chi, and R.A. Flavell Cutting edge: regulation of T cell trafficking and primary immune responses by sphingosine 1-phosphate receptor 1 J. Immunol. 174 2005 2485 2488
15. M.H. Graler Immunological effects of transgenic constitutive expression of the type 1 sphingosine 1-phosphate receptor by mouse lymphocytes J. Immunol. 174 2005 1997 2003
16. L.G. Ledgerwood The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics Nat. Immunol. 9 2008 42 53
17. C. Weber Discontinued postnatal thymocyte development in sphingosine 1-phosphate-lyase-deficient mice J. Immunol. 183 2009 4292 4301
18. P. Vogel Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions PLoS ONE 4 2009 e4112
19. S. Thangada Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics J. Exp. Med. 207 2010 1475 1483
20. L.R. Shiow CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs Nature 440 2006 540 544
21. C.M. Carlson Kruppel-like factor 2 regulates thymocyte and T-cell migration Nature 442 2006 299 302
22. S.H. Wei Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses Nat. Immunol. 6 2005 1228 1235
23. F. Mullershausen Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors Nat. Chem. Biol. 5 2009 428 434
24. S.G. Payne The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors Blood 109 2007 1077 1085
25. M.L. Allende S1P1 receptor directs the release of immature B cells from bone marrow into blood J. Exp. Med. 207 2010 1113 1124
26. J.P. Pereira A role for S1P and S1P1 in immature B cell egress from mouse bone marrow PLoS ONE 5 2010 e9277
27. G. Cinamon Follicular shuttling of marginal zone B cells facilitates antigen transport Nat. Immunol. 9 2008 54 62
28. M. Ishii Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis Nature 458 2009 524 528
29. T. Walzer Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor Nat. Immunol. 8 2007 1337 1344
30. C.N. Jenne T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow J. Exp. Med. 206 2009 2469 2481
31. Y. Maeda Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3 J. Immunol. 178 2007 3437 3446
32. J. Michaud Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation J. Immunol. 184 2010 1475 1483
33. P. Puneet SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis Science 328 2010 1290 1294
34. M. Karin, and E. Gallagher TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes Immunol. Rev. 228 2009 225 240
35. G. Huang Regulation of JNK and p38 MAPK in the immune system: signal integration, propagation and termination Cytokine 48 2009 161 169
36. V.G. Bhoj, and Z.J. Chen Ubiquitylation in innate and adaptive immunity Nature 458 2009 430 437
37. S.E. Alvarez Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2 Nature 465 2010 1084 1088
38. F. Niessen Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation Nature 452 2008 654 658
39. K. Takabe Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets Pharmacol. Rev. 60 2008 181 195
40. A. Olivera The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis Immunity 26 2007 287 297
41. P.N. Pushparaj Sphingosine kinase 1 is pivotal for Fc epsilon RI-mediated mast cell signaling and functional responses in vitro and in vivo J. Immunol. 183 2009 221 227
42. C.A. Oskeritzian Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions Blood 111 2008 4193 4200
43. C.A. Oskeritzian Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema J. Exp. Med. 207 2010 465 474
44. A. Olivera Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice J. Clin. Invest. 120 2010 1429 1440
45. T. Hla The vascular S1P gradient - cellular sources and biological significance Biochim. Biophys. Acta 1781 2008 477 482
46. E. Camerer Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice J. Clin. Invest. 119 2009 1871 1879
47. D.A. Baker Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis J. Immunol. 185 2010 2570 2579
48. W.Q. Lai Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis J. Immunol. 181 2008 8010 8017
49. A.J. Snider A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis FASEB J. 23 2009 143 152
50. W.Q. Lai The role of sphingosine kinase in a murine model of allergic asthma J. Immunol. 180 2008 4323 4329
51. J. Zhu Differentiation of effector CD4 T cell populations Annu. Rev. Immunol. 28 2010 445 489
52. + regulatory T cells: more of the same or a division of labor? Immunity 30 2009 626 635
53. G. Liu The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR Nat. Immunol. 10 2009 769 777
54. + T-regulatory cells and enhances their functional activity J. Immunol. 175 2005 7973 7980
55. + regulatory T cells J. Immunol. 178 2007 2458 2468
56. reg cells Nat. Immunol. 11 2010 1047 1056
57. 3+ regulators J. Immunol. 180 2008 7636 7647
58. M. Sekiguchi Role of sphingosine 1-phosphate in the pathogenesis of Sjogren's syndrome J. Immunol. 180 2008 1921 1928
59. W. Wang Type 1 sphingosine 1-phosphate G protein-coupled receptor (S1P1) mediation of enhanced IL-4 generation by CD4 T cells from S1P1 transgenic mice J. Immunol. 178 2007 4885 4890
60. M.C. Huang Th17 augmentation in OTII TCR plus T cell-selective type 1 sphingosine 1-phosphate receptor double transgenic mice J. Immunol. 178 2007 6806 6813
61. W. Wang Type 4 sphingosine 1-phosphate G protein-coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration FASEB J. 19 2005 1731 1733
62. M.G. Sanna Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate J. Biol. Chem. 279 2004 13839 13848
63. V. Brinkmann FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system Br. J. Pharmacol. 158 2009 1173 1182
64. L. Kappos A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis N. Engl. J. Med. 362 2010 387 401
65. J.A. Cohen Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis N. Engl. J. Med. 362 2010 402 415
66. E. Jo S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate Chem. Biol. 12 2005 703 715
67. H. Shimizu KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts Circulation 111 2005 222 229
68. S.E. Wenderfer Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist Kidney Int. 74 2008 1319 1326
69. M.G. Sanna Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo Nat. Chem. Biol. 2 2006 434 441
70. M.D. Davis Sphingosine 1-phosphate analogs as receptor antagonists J. Biol. Chem. 280 2005 9833 9841
71. T. Ohmori Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2 Cardiovasc. Res. 58 2003 170 177
72. N.J. Pyne, and S. Pyne Sphingosine 1-phosphate and cancer Nat. Rev. Cancer 10 2010 489 503
73. W.Q. Lai Distinct roles of sphingosine kinase 1 and 2 in murine collagen-induced arthritis J. Immunol. 183 2009 2097 2103
74. S.W. Paugh A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia Blood 112 2008 1382 1391
75. D. Kapitonov Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts Cancer Res. 69 2009 6915 6923
76. L. Wong Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases J. Med. Chem. 52 2009 3618 3626
77. K.J. French Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2 J. Pharmacol. Exp. Ther. 333 2010 129 139
78. V. Beljanski A novel sphingosine kinase inhibitor induces autophagy in tumor cells J. Pharmacol. Exp. Ther. 333 2010 454 464
79. B. Visentin Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages Cancer Cell 9 2006 225 238
80. N. O'Brien Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies J. Lipid Res. 50 2009 2245 2257
81. H. Fyrst, and J.D. Saba An update on sphingosine-1-phosphate and other sphingolipid mediators Nat. Chem. Biol. 6 2010 489 497